Serum Markers in Preeclamptic Women

This study has been completed.
Sponsor:
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01361737
First received: May 25, 2011
Last updated: July 3, 2011
Last verified: May 2011
  Purpose

Could possible markers in serum obtained in the first trimester predict the human-pregnancy specific disorder pre-eclampsia?


Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Study Start Date: January 1999
Study Completion Date: May 2004
Primary Completion Date: January 1999 (Final data collection date for primary outcome measure)
Groups/Cohorts
preeclampsia
  • Control group: 86 healthy women not developing preeclampsia (PE)
  • Case group: 43 women developing PE

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Norwegian pregnant women

Criteria

Inclusion Criteria:

  • previous healthy

Exclusion Criteria:

  • Previous inflammatory diseases
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01361737

Locations
Norway
Oslo University Hospital, Rikshospitalet
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
  More Information

No publications provided

Responsible Party: Oslo University Hospital, Rikshospitalet, OsloUH
ClinicalTrials.gov Identifier: NCT01361737     History of Changes
Other Study ID Numbers: NOSERPE11
Study First Received: May 25, 2011
Last Updated: July 3, 2011
Health Authority: Norway: University of Oslo

Keywords provided by Oslo University Hospital:
Preeclampsia
serological bio-bank
adiponectin
suPAR

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on April 14, 2014